ESRX - Express Scripts Holding Company

ESRX

$92.33 +0.00 (+0.00%) Last updated: Apr 16, 2026 00:54

52-Week Range

$92.33

$73.86 $92.33 $110.80

Fundamentals Overview

Express Scripts Holding Company is in the middle of its 52-week range with attractive valuation, trading relatively flat today.

Valuation attractive

P/E 10.7 PEG 0.3 P/B 2.96

Profitability

Net margin 4.5%

Risk (Beta)

0.9 — in line vol

Earnings & growth

EPS $8.63 Rev -0.3% Profit +22.1% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 35% confidence Risk: Moderate Volatility — Beta 0.9. Diversify and only invest what you can afford to lose.

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

N/A

P/E (TTM)

10.7

EPS (TTM)

$8.63

Dividend Yield

N/A

52-Week Range

$73.86 - $110.80

Volume vs Avg

N/A

Beta

0.9

About

Express Scripts is a pharmacy benefit management (PBM) organization founded in 1986. It offers integrated services like pharmacy claims processing, home delivery, formulary management, specialty pharmacy via Accredo, and data-driven drug utilization insights. The company is a subsidiary of Cigna following a $54 billion acquisition completed in December 2018.

Sector: Healthcare

Headquarters: US

IPO Date: Jun 1992

Beta: 0.9 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	10.7
PEG (TTM)	0.3
P/B (TTM)	2.96
P/S (TTM)	N/A
Liquidity & enterprise
Current Ratio (TTM)	0.67
Quick Ratio (TTM)	0.55
Cash Ratio (TTM)	0.13
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	4.51%
Gross margin (TTM)	8.76%
Operating margin (TTM)	5.49%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ESRX.

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.